Novartis Pharmaceuticals recalls
Novartis Pharmaceuticals has 33 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 19 Aug 2026. 3 are still ongoing. 1 was reported in the last 12 months.
Total recalls33since 2013
Last 12 months1reported
Class I39% of total
Ongoing3latest 19 Aug 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 3 9%Class II 17 52%Class III 13 39%
Why novartis pharmaceuticals is recalled
Product types
Brands
By year
Ongoing novartis pharmaceuticals recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Diovan (valsartan) 160 mg recalled by Novartis PharmaceuticalsDiovan | Novartis Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS I | Sandimmune Oral Solution (cyclosporine oral solution, USP) 100 mg/mL recalled | Novartis Pharmaceuticals | Other | Nationwide |
| Drug | CLASS I | Sandimmune Oral Solution (cyclosporine oral solution, USP) 100 mg/mL recalled | Novartis Pharmaceuticals | Other | Nationwide |
All novartis pharmaceuticals recalls, newest first
33 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.